Study to Compare Gabapentin to Tramadol in Children With Chronic Neuropathic or Mixed Pain
Status:
Terminated
Trial end date:
2019-06-18
Target enrollment:
Participant gender:
Summary
This study evaluates the efficacy and safety of gabapentin relative to tramadol for the
treatment of chronic, neuropathic or mixed pain in the paediatric population. Children from 3
months to less than 18 years of age experiencing moderate to severe chronic pain will receive
either gabapentin or tramadol for 15 weeks. The difference in average pain scores between
treatment arms at the end of the treatment period will be assessed.